AI Terminal
Ambu
Director's Dealing • May 16, 2025
3353_rpt_2025-05-16_56277c33-c8cc-4d96-bfb9-df882798ab6c.pdf
Director's Dealing
Open in ViewerOpens in native device viewer
Reporting of transactions made by persons discharging managerial responsibilities
16.5.2025 09:55:32 CEST | Ambu A/S | Managers' Transactions
Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S and/or their closely associated persons related to Ambu A/S's shares admitted to trading and official listing on Nasdaq Copenhagen A/S.
The attached document discloses the data of the transactions made in Ambu shares.
Company announcement no. 15
Contacts
- Anders Hjort, Head of Investor Relations, +45 2892 8881, [email protected]
- Tine Bjørn Schmidt, Director of Corporate Communications, +45 2264 0697, [email protected]
About Ambu A/S
Since 1937, Ambu has been rethinking solutions together with healthcare professionals to save lives and improve patient care. From development and manufacturing to distribution and sale, we oversee the entire product lifecycle for our healthcare solutions across the fields of single-use endoscopy, anaesthesia and patient monitoring. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our high-quality solutions.
Headquartered in Denmark, Ambu employs around 5,000 people in North America, Europe, Latin America and Asia Pacific.
For more information, please visit Ambu.com.